nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—CYP2C19—epilepsy syndrome	0.118	0.643	CbGaD
Acenocoumarol—ALB—epilepsy syndrome	0.0656	0.357	CbGaD
Acenocoumarol—Warfarin—Phenytoin—epilepsy syndrome	0.053	0.147	CrCrCtD
Acenocoumarol—Warfarin—Oxcarbazepine—epilepsy syndrome	0.0451	0.125	CrCrCtD
Acenocoumarol—Phenprocoumon—Phenytoin—epilepsy syndrome	0.0448	0.124	CrCrCtD
Acenocoumarol—Nitrazepam—Clonazepam—epilepsy syndrome	0.0399	0.111	CrCrCtD
Acenocoumarol—Flunitrazepam—Clonazepam—epilepsy syndrome	0.0384	0.107	CrCrCtD
Acenocoumarol—Flunitrazepam—Midazolam—epilepsy syndrome	0.0367	0.102	CrCrCtD
Acenocoumarol—Flunitrazepam—Clobazam—epilepsy syndrome	0.0352	0.0978	CrCrCtD
Acenocoumarol—Nitrazepam—Diazepam—epilepsy syndrome	0.0339	0.0943	CrCrCtD
Acenocoumarol—Flunitrazepam—Diazepam—epilepsy syndrome	0.0327	0.0909	CrCrCtD
Acenocoumarol—ALB—Oxcarbazepine—epilepsy syndrome	0.0192	0.0525	CbGbCtD
Acenocoumarol—ALB—Fosphenytoin—epilepsy syndrome	0.0168	0.0459	CbGbCtD
Acenocoumarol—ALB—Clonazepam—epilepsy syndrome	0.0152	0.0415	CbGbCtD
Acenocoumarol—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0124	0.0341	CbGbCtD
Acenocoumarol—ALB—Rufinamide—epilepsy syndrome	0.0124	0.0339	CbGbCtD
Acenocoumarol—CYP2C19—Trimethadione—epilepsy syndrome	0.0116	0.0317	CbGbCtD
Acenocoumarol—CYP2C19—Felbamate—epilepsy syndrome	0.0116	0.0317	CbGbCtD
Acenocoumarol—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0109	0.0298	CbGbCtD
Acenocoumarol—ALB—Phenytoin—epilepsy syndrome	0.0108	0.0296	CbGbCtD
Acenocoumarol—ALB—Propofol—epilepsy syndrome	0.0101	0.0276	CbGbCtD
Acenocoumarol—CYP2C9—Trimethadione—epilepsy syndrome	0.00961	0.0263	CbGbCtD
Acenocoumarol—CYP2C19—Clobazam—epilepsy syndrome	0.00942	0.0258	CbGbCtD
Acenocoumarol—ALB—Diazepam—epilepsy syndrome	0.00913	0.025	CbGbCtD
Acenocoumarol—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00904	0.0248	CbGbCtD
Acenocoumarol—CYP2C19—Carbamazepine—epilepsy syndrome	0.00781	0.0214	CbGbCtD
Acenocoumarol—CYP2C19—Primidone—epilepsy syndrome	0.00729	0.02	CbGbCtD
Acenocoumarol—CYP1A2—Carbamazepine—epilepsy syndrome	0.0072	0.0197	CbGbCtD
Acenocoumarol—CYP2C19—Phenytoin—epilepsy syndrome	0.007	0.0192	CbGbCtD
Acenocoumarol—CYP1A2—Primidone—epilepsy syndrome	0.00673	0.0184	CbGbCtD
Acenocoumarol—CYP2C19—Propofol—epilepsy syndrome	0.00653	0.0179	CbGbCtD
Acenocoumarol—CYP2C9—Carbamazepine—epilepsy syndrome	0.00649	0.0178	CbGbCtD
Acenocoumarol—CYP2C19—Phenobarbital—epilepsy syndrome	0.00624	0.0171	CbGbCtD
Acenocoumarol—CYP2C9—Primidone—epilepsy syndrome	0.00606	0.0166	CbGbCtD
Acenocoumarol—CYP1A2—Propofol—epilepsy syndrome	0.00603	0.0165	CbGbCtD
Acenocoumarol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00601	0.0165	CbGbCtD
Acenocoumarol—CYP2C19—Diazepam—epilepsy syndrome	0.00592	0.0162	CbGbCtD
Acenocoumarol—CYP2C9—Phenytoin—epilepsy syndrome	0.00582	0.016	CbGbCtD
Acenocoumarol—CYP2C19—Zonisamide—epilepsy syndrome	0.00578	0.0158	CbGbCtD
Acenocoumarol—CYP1A2—Phenobarbital—epilepsy syndrome	0.00576	0.0158	CbGbCtD
Acenocoumarol—CYP3A4—Felbamate—epilepsy syndrome	0.00559	0.0153	CbGbCtD
Acenocoumarol—CYP3A4—Trimethadione—epilepsy syndrome	0.00559	0.0153	CbGbCtD
Acenocoumarol—CYP1A2—Diazepam—epilepsy syndrome	0.00546	0.015	CbGbCtD
Acenocoumarol—CYP2C9—Propofol—epilepsy syndrome	0.00543	0.0149	CbGbCtD
Acenocoumarol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00525	0.0144	CbGbCtD
Acenocoumarol—CYP2C9—Phenobarbital—epilepsy syndrome	0.00519	0.0142	CbGbCtD
Acenocoumarol—CYP2C9—Diazepam—epilepsy syndrome	0.00492	0.0135	CbGbCtD
Acenocoumarol—CYP3A4—Clonazepam—epilepsy syndrome	0.00475	0.013	CbGbCtD
Acenocoumarol—CYP2C19—Valproic Acid—epilepsy syndrome	0.00466	0.0128	CbGbCtD
Acenocoumarol—CYP3A4—Clobazam—epilepsy syndrome	0.00456	0.0125	CbGbCtD
Acenocoumarol—CYP1A2—Valproic Acid—epilepsy syndrome	0.0043	0.0118	CbGbCtD
Acenocoumarol—CYP2C19—Topiramate—epilepsy syndrome	0.00421	0.0115	CbGbCtD
Acenocoumarol—CYP2C9—Valproic Acid—epilepsy syndrome	0.00388	0.0106	CbGbCtD
Acenocoumarol—CYP3A4—Rufinamide—epilepsy syndrome	0.00387	0.0106	CbGbCtD
Acenocoumarol—CYP3A4—Carbamazepine—epilepsy syndrome	0.00377	0.0103	CbGbCtD
Acenocoumarol—CYP3A4—Primidone—epilepsy syndrome	0.00352	0.00965	CbGbCtD
Acenocoumarol—CYP3A4—Phenytoin—epilepsy syndrome	0.00339	0.00927	CbGbCtD
Acenocoumarol—CYP3A4—Propofol—epilepsy syndrome	0.00316	0.00865	CbGbCtD
Acenocoumarol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00302	0.00827	CbGbCtD
Acenocoumarol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00302	0.00827	CbGbCtD
Acenocoumarol—CYP3A4—Midazolam—epilepsy syndrome	0.00298	0.00815	CbGbCtD
Acenocoumarol—CYP3A4—Diazepam—epilepsy syndrome	0.00286	0.00784	CbGbCtD
Acenocoumarol—CYP3A4—Zonisamide—epilepsy syndrome	0.00279	0.00765	CbGbCtD
Acenocoumarol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00225	0.00618	CbGbCtD
Acenocoumarol—CYP3A4—Topiramate—epilepsy syndrome	0.00203	0.00557	CbGbCtD
Acenocoumarol—VKORC1—Bortezomib—Lacosamide—epilepsy syndrome	0.00133	1	CbGdCrCtD
Acenocoumarol—Haemorrhage—Trimethadione—epilepsy syndrome	0.00048	0.00689	CcSEcCtD
Acenocoumarol—Coagulopathy—Valproic Acid—epilepsy syndrome	0.000479	0.00688	CcSEcCtD
Acenocoumarol—Metrorrhagia—Pregabalin—epilepsy syndrome	0.000472	0.00677	CcSEcCtD
Acenocoumarol—Melaena—Lamotrigine—epilepsy syndrome	0.000458	0.00658	CcSEcCtD
Acenocoumarol—Menorrhagia—Pregabalin—epilepsy syndrome	0.000455	0.00654	CcSEcCtD
Acenocoumarol—Liver injury—Valproic Acid—epilepsy syndrome	0.000443	0.00636	CcSEcCtD
Acenocoumarol—Haematuria—Rufinamide—epilepsy syndrome	0.000443	0.00636	CcSEcCtD
Acenocoumarol—Coagulopathy—Pregabalin—epilepsy syndrome	0.000433	0.00622	CcSEcCtD
Acenocoumarol—Alopecia—Trimethadione—epilepsy syndrome	0.000424	0.00609	CcSEcCtD
Acenocoumarol—Menorrhagia—Gabapentin—epilepsy syndrome	0.000418	0.00599	CcSEcCtD
Acenocoumarol—Coagulopathy—Gabapentin—epilepsy syndrome	0.000397	0.0057	CcSEcCtD
Acenocoumarol—Metrorrhagia—Topiramate—epilepsy syndrome	0.000364	0.00523	CcSEcCtD
Acenocoumarol—Haematuria—Acetazolamide—epilepsy syndrome	0.00036	0.00517	CcSEcCtD
Acenocoumarol—Menorrhagia—Topiramate—epilepsy syndrome	0.000351	0.00504	CcSEcCtD
Acenocoumarol—Neoplasm—Valproic Acid—epilepsy syndrome	0.000337	0.00484	CcSEcCtD
Acenocoumarol—Decreased appetite—Primidone—epilepsy syndrome	0.000337	0.00484	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Primidone—epilepsy syndrome	0.000335	0.0048	CcSEcCtD
Acenocoumarol—Coagulopathy—Topiramate—epilepsy syndrome	0.000334	0.0048	CcSEcCtD
Acenocoumarol—Melaena—Pregabalin—epilepsy syndrome	0.000329	0.00473	CcSEcCtD
Acenocoumarol—Skin exfoliation—Pregabalin—epilepsy syndrome	0.000322	0.00462	CcSEcCtD
Acenocoumarol—Body temperature increased—Amobarbital—epilepsy syndrome	0.000318	0.00457	CcSEcCtD
Acenocoumarol—Haemoglobin—Propofol—epilepsy syndrome	0.000316	0.00454	CcSEcCtD
Acenocoumarol—Haemorrhage—Propofol—epilepsy syndrome	0.000315	0.00452	CcSEcCtD
Acenocoumarol—Nitrazepam—GABRD—epilepsy syndrome	0.000309	0.137	CrCbGaD
Acenocoumarol—Neoplasm—Pregabalin—epilepsy syndrome	0.000305	0.00438	CcSEcCtD
Acenocoumarol—Melaena—Gabapentin—epilepsy syndrome	0.000302	0.00433	CcSEcCtD
Acenocoumarol—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000296	0.00425	CcSEcCtD
Acenocoumarol—Decreased appetite—Trimethadione—epilepsy syndrome	0.000296	0.00425	CcSEcCtD
Acenocoumarol—Skin exfoliation—Gabapentin—epilepsy syndrome	0.000295	0.00424	CcSEcCtD
Acenocoumarol—Haematuria—Felbamate—epilepsy syndrome	0.000289	0.00416	CcSEcCtD
Acenocoumarol—Haematuria—Zonisamide—epilepsy syndrome	0.000283	0.00407	CcSEcCtD
Acenocoumarol—Haemoglobin—Felbamate—epilepsy syndrome	0.000274	0.00393	CcSEcCtD
Acenocoumarol—Haemorrhage—Felbamate—epilepsy syndrome	0.000273	0.00391	CcSEcCtD
Acenocoumarol—Haematuria—Oxcarbazepine—epilepsy syndrome	0.00027	0.00387	CcSEcCtD
Acenocoumarol—Alopecia—Levetiracetam—epilepsy syndrome	0.000269	0.00386	CcSEcCtD
Acenocoumarol—Haematuria—Carbamazepine—epilepsy syndrome	0.000259	0.00372	CcSEcCtD
Acenocoumarol—Haemoglobin—Clonazepam—epilepsy syndrome	0.000258	0.00371	CcSEcCtD
Acenocoumarol—Decreased appetite—Rufinamide—epilepsy syndrome	0.000258	0.0037	CcSEcCtD
Acenocoumarol—Haemorrhage—Clonazepam—epilepsy syndrome	0.000257	0.00369	CcSEcCtD
Acenocoumarol—Haemoglobin—Phenytoin—epilepsy syndrome	0.000257	0.00369	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000256	0.00367	CcSEcCtD
Acenocoumarol—Vomiting—Amobarbital—epilepsy syndrome	0.000256	0.00367	CcSEcCtD
Acenocoumarol—Haemorrhage—Phenytoin—epilepsy syndrome	0.000255	0.00367	CcSEcCtD
Acenocoumarol—Melaena—Topiramate—epilepsy syndrome	0.000254	0.00365	CcSEcCtD
Acenocoumarol—Dermatitis—Amobarbital—epilepsy syndrome	0.000253	0.00364	CcSEcCtD
Acenocoumarol—Haematuria—Lamotrigine—epilepsy syndrome	0.00025	0.00359	CcSEcCtD
Acenocoumarol—Vomiting—Primidone—epilepsy syndrome	0.000246	0.00354	CcSEcCtD
Acenocoumarol—Dermatitis—Primidone—epilepsy syndrome	0.000244	0.0035	CcSEcCtD
Acenocoumarol—Nitrazepam—SCN1A—epilepsy syndrome	0.000242	0.107	CrCbGaD
Acenocoumarol—Alopecia—Felbamate—epilepsy syndrome	0.000241	0.00346	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.00024	0.00345	CcSEcCtD
Acenocoumarol—Urticaria—Phenobarbital—epilepsy syndrome	0.00024	0.00344	CcSEcCtD
Acenocoumarol—Nausea—Amobarbital—epilepsy syndrome	0.000239	0.00343	CcSEcCtD
Acenocoumarol—Body temperature increased—Phenobarbital—epilepsy syndrome	0.000239	0.00343	CcSEcCtD
Acenocoumarol—Haemoglobin—Lamotrigine—epilepsy syndrome	0.000237	0.0034	CcSEcCtD
Acenocoumarol—Alopecia—Zonisamide—epilepsy syndrome	0.000236	0.00338	CcSEcCtD
Acenocoumarol—Haemorrhage—Lamotrigine—epilepsy syndrome	0.000236	0.00338	CcSEcCtD
Acenocoumarol—Neoplasm—Topiramate—epilepsy syndrome	0.000235	0.00338	CcSEcCtD
Acenocoumarol—Decreased appetite—Clobazam—epilepsy syndrome	0.000235	0.00337	CcSEcCtD
Acenocoumarol—Nitrazepam—GABRG2—epilepsy syndrome	0.000235	0.104	CrCbGaD
Acenocoumarol—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000233	0.00335	CcSEcCtD
Acenocoumarol—Nausea—Primidone—epilepsy syndrome	0.00023	0.0033	CcSEcCtD
Acenocoumarol—Alopecia—Clonazepam—epilepsy syndrome	0.000227	0.00326	CcSEcCtD
Acenocoumarol—Alopecia—Oxcarbazepine—epilepsy syndrome	0.000224	0.00322	CcSEcCtD
Acenocoumarol—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000222	0.00319	CcSEcCtD
Acenocoumarol—Urticaria—Lacosamide—epilepsy syndrome	0.000221	0.00317	CcSEcCtD
Acenocoumarol—Body temperature increased—Lacosamide—epilepsy syndrome	0.00022	0.00316	CcSEcCtD
Acenocoumarol—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000218	0.00313	CcSEcCtD
Acenocoumarol—Vomiting—Trimethadione—epilepsy syndrome	0.000217	0.00311	CcSEcCtD
Acenocoumarol—Alopecia—Carbamazepine—epilepsy syndrome	0.000215	0.00309	CcSEcCtD
Acenocoumarol—Dermatitis—Trimethadione—epilepsy syndrome	0.000215	0.00308	CcSEcCtD
Acenocoumarol—Urticaria—Clobazam—epilepsy syndrome	0.000215	0.00308	CcSEcCtD
Acenocoumarol—Body temperature increased—Clobazam—epilepsy syndrome	0.000213	0.00307	CcSEcCtD
Acenocoumarol—Decreased appetite—Acetazolamide—epilepsy syndrome	0.000209	0.003	CcSEcCtD
Acenocoumarol—Flunitrazepam—GABRA5—epilepsy syndrome	0.000209	0.0927	CrCbGaD
Acenocoumarol—Alopecia—Lamotrigine—epilepsy syndrome	0.000208	0.00299	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000208	0.00298	CcSEcCtD
Acenocoumarol—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000205	0.00294	CcSEcCtD
Acenocoumarol—Diarrhoea—Rufinamide—epilepsy syndrome	0.000203	0.00291	CcSEcCtD
Acenocoumarol—Nausea—Trimethadione—epilepsy syndrome	0.000202	0.00291	CcSEcCtD
Acenocoumarol—Vomiting—Phenobarbital—epilepsy syndrome	0.000192	0.00276	CcSEcCtD
Acenocoumarol—Urticaria—Acetazolamide—epilepsy syndrome	0.000191	0.00275	CcSEcCtD
Acenocoumarol—Diarrhoea—Lacosamide—epilepsy syndrome	0.00019	0.00273	CcSEcCtD
Acenocoumarol—Body temperature increased—Acetazolamide—epilepsy syndrome	0.00019	0.00273	CcSEcCtD
Acenocoumarol—Dermatitis—Phenobarbital—epilepsy syndrome	0.00019	0.00273	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000189	0.00271	CcSEcCtD
Acenocoumarol—Nitrazepam—GABRA5—epilepsy syndrome	0.000189	0.0837	CrCbGaD
Acenocoumarol—Nitrazepam—GABRB3—epilepsy syndrome	0.000189	0.0837	CrCbGaD
Acenocoumarol—Vomiting—Rufinamide—epilepsy syndrome	0.000188	0.00271	CcSEcCtD
Acenocoumarol—Haemoglobin—Valproic Acid—epilepsy syndrome	0.000188	0.0027	CcSEcCtD
Acenocoumarol—Decreased appetite—Levetiracetam—epilepsy syndrome	0.000188	0.0027	CcSEcCtD
Acenocoumarol—Haemorrhage—Valproic Acid—epilepsy syndrome	0.000187	0.00269	CcSEcCtD
Acenocoumarol—Dermatitis—Rufinamide—epilepsy syndrome	0.000187	0.00268	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000186	0.00268	CcSEcCtD
Acenocoumarol—Diarrhoea—Clobazam—epilepsy syndrome	0.000185	0.00265	CcSEcCtD
Acenocoumarol—Decreased appetite—Fosphenytoin—epilepsy syndrome	0.000181	0.0026	CcSEcCtD
Acenocoumarol—Haematuria—Pregabalin—epilepsy syndrome	0.00018	0.00258	CcSEcCtD
Acenocoumarol—Flunitrazepam—GABRA1—epilepsy syndrome	0.000179	0.0795	CrCbGaD
Acenocoumarol—Nausea—Phenobarbital—epilepsy syndrome	0.000179	0.00257	CcSEcCtD
Acenocoumarol—Urticaria—Propofol—epilepsy syndrome	0.000178	0.00255	CcSEcCtD
Acenocoumarol—Vomiting—Lacosamide—epilepsy syndrome	0.000177	0.00254	CcSEcCtD
Acenocoumarol—Body temperature increased—Propofol—epilepsy syndrome	0.000177	0.00254	CcSEcCtD
Acenocoumarol—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000177	0.00254	CcSEcCtD
Acenocoumarol—Nausea—Rufinamide—epilepsy syndrome	0.000176	0.00253	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000175	0.00252	CcSEcCtD
Acenocoumarol—Dermatitis—Lacosamide—epilepsy syndrome	0.000175	0.00252	CcSEcCtD
Acenocoumarol—Decreased appetite—Diazepam—epilepsy syndrome	0.000174	0.0025	CcSEcCtD
Acenocoumarol—Urticaria—Midazolam—epilepsy syndrome	0.000174	0.00249	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000173	0.00248	CcSEcCtD
Acenocoumarol—Vomiting—Clobazam—epilepsy syndrome	0.000172	0.00247	CcSEcCtD
Acenocoumarol—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000171	0.00245	CcSEcCtD
Acenocoumarol—Dermatitis—Clobazam—epilepsy syndrome	0.00017	0.00244	CcSEcCtD
Acenocoumarol—Haemoglobin—Pregabalin—epilepsy syndrome	0.00017	0.00244	CcSEcCtD
Acenocoumarol—Haemorrhage—Pregabalin—epilepsy syndrome	0.000169	0.00243	CcSEcCtD
Acenocoumarol—Decreased appetite—Felbamate—epilepsy syndrome	0.000168	0.00242	CcSEcCtD
Acenocoumarol—Urticaria—Fosphenytoin—epilepsy syndrome	0.000166	0.00238	CcSEcCtD
Acenocoumarol—Alopecia—Valproic Acid—epilepsy syndrome	0.000165	0.00238	CcSEcCtD
Acenocoumarol—Nausea—Lacosamide—epilepsy syndrome	0.000165	0.00237	CcSEcCtD
Acenocoumarol—Nitrazepam—GABRB2—epilepsy syndrome	0.000165	0.0732	CrCbGaD
Acenocoumarol—Haematuria—Gabapentin—epilepsy syndrome	0.000165	0.00237	CcSEcCtD
Acenocoumarol—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000165	0.00237	CcSEcCtD
Acenocoumarol—Decreased appetite—Zonisamide—epilepsy syndrome	0.000165	0.00237	CcSEcCtD
Acenocoumarol—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000165	0.00236	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000164	0.00235	CcSEcCtD
Acenocoumarol—Nitrazepam—GABRA1—epilepsy syndrome	0.000162	0.0718	CrCbGaD
Acenocoumarol—Urticaria—Vigabatrin—epilepsy syndrome	0.000161	0.00232	CcSEcCtD
Acenocoumarol—Hypersensitivity—Midazolam—epilepsy syndrome	0.000161	0.00231	CcSEcCtD
Acenocoumarol—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000161	0.00231	CcSEcCtD
Acenocoumarol—Nausea—Clobazam—epilepsy syndrome	0.00016	0.0023	CcSEcCtD
Acenocoumarol—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000159	0.00228	CcSEcCtD
Acenocoumarol—Urticaria—Diazepam—epilepsy syndrome	0.000159	0.00228	CcSEcCtD
Acenocoumarol—Decreased appetite—Clonazepam—epilepsy syndrome	0.000159	0.00228	CcSEcCtD
Acenocoumarol—Decreased appetite—Phenytoin—epilepsy syndrome	0.000158	0.00226	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000158	0.00226	CcSEcCtD
Acenocoumarol—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000157	0.00225	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000157	0.00225	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000156	0.00224	CcSEcCtD
Acenocoumarol—Haemorrhage—Gabapentin—epilepsy syndrome	0.000155	0.00223	CcSEcCtD
Acenocoumarol—Urticaria—Felbamate—epilepsy syndrome	0.000154	0.00221	CcSEcCtD
Acenocoumarol—Body temperature increased—Felbamate—epilepsy syndrome	0.000153	0.0022	CcSEcCtD
Acenocoumarol—Vomiting—Acetazolamide—epilepsy syndrome	0.000153	0.0022	CcSEcCtD
Acenocoumarol—Diarrhoea—Propofol—epilepsy syndrome	0.000153	0.0022	CcSEcCtD
Acenocoumarol—Urticaria—Zonisamide—epilepsy syndrome	0.000151	0.00216	CcSEcCtD
Acenocoumarol—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000151	0.00216	CcSEcCtD
Acenocoumarol—Body temperature increased—Zonisamide—epilepsy syndrome	0.00015	0.00215	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.00015	0.00215	CcSEcCtD
Acenocoumarol—Alopecia—Pregabalin—epilepsy syndrome	0.00015	0.00215	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.00015	0.00215	CcSEcCtD
Acenocoumarol—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000148	0.00212	CcSEcCtD
Acenocoumarol—Hypersensitivity—Diazepam—epilepsy syndrome	0.000147	0.00212	CcSEcCtD
Acenocoumarol—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000145	0.00209	CcSEcCtD
Acenocoumarol—Urticaria—Clonazepam—epilepsy syndrome	0.000145	0.00208	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000145	0.00207	CcSEcCtD
Acenocoumarol—Body temperature increased—Clonazepam—epilepsy syndrome	0.000144	0.00207	CcSEcCtD
Acenocoumarol—Urticaria—Phenytoin—epilepsy syndrome	0.000144	0.00207	CcSEcCtD
Acenocoumarol—Body temperature increased—Phenytoin—epilepsy syndrome	0.000143	0.00206	CcSEcCtD
Acenocoumarol—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000143	0.00206	CcSEcCtD
Acenocoumarol—Nausea—Acetazolamide—epilepsy syndrome	0.000143	0.00205	CcSEcCtD
Acenocoumarol—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000143	0.00205	CcSEcCtD
Acenocoumarol—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000143	0.00205	CcSEcCtD
Acenocoumarol—Vomiting—Propofol—epilepsy syndrome	0.000142	0.00204	CcSEcCtD
Acenocoumarol—Dermatitis—Propofol—epilepsy syndrome	0.000141	0.00202	CcSEcCtD
Acenocoumarol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.00014	0.002	CcSEcCtD
Acenocoumarol—Vomiting—Midazolam—epilepsy syndrome	0.000139	0.002	CcSEcCtD
Acenocoumarol—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000139	0.002	CcSEcCtD
Acenocoumarol—Haematuria—Topiramate—epilepsy syndrome	0.000139	0.00199	CcSEcCtD
Acenocoumarol—Dermatitis—Midazolam—epilepsy syndrome	0.000138	0.00198	CcSEcCtD
Acenocoumarol—Urticaria—Carbamazepine—epilepsy syndrome	0.000138	0.00198	CcSEcCtD
Acenocoumarol—Vomiting—Levetiracetam—epilepsy syndrome	0.000137	0.00197	CcSEcCtD
Acenocoumarol—Alopecia—Gabapentin—epilepsy syndrome	0.000137	0.00197	CcSEcCtD
Acenocoumarol—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000137	0.00197	CcSEcCtD
Acenocoumarol—Diarrhoea—Diazepam—epilepsy syndrome	0.000137	0.00197	CcSEcCtD
Acenocoumarol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000136	0.00195	CcSEcCtD
Acenocoumarol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000135	0.00193	CcSEcCtD
Acenocoumarol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000134	0.00192	CcSEcCtD
Acenocoumarol—Urticaria—Lamotrigine—epilepsy syndrome	0.000133	0.00191	CcSEcCtD
Acenocoumarol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000133	0.00191	CcSEcCtD
Acenocoumarol—Nausea—Propofol—epilepsy syndrome	0.000133	0.00191	CcSEcCtD
Acenocoumarol—Vomiting—Fosphenytoin—epilepsy syndrome	0.000133	0.0019	CcSEcCtD
Acenocoumarol—Diarrhoea—Felbamate—epilepsy syndrome	0.000132	0.0019	CcSEcCtD
Acenocoumarol—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000132	0.0019	CcSEcCtD
Acenocoumarol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000131	0.00189	CcSEcCtD
Acenocoumarol—Haemoglobin—Topiramate—epilepsy syndrome	0.000131	0.00188	CcSEcCtD
Acenocoumarol—Haemorrhage—Topiramate—epilepsy syndrome	0.000131	0.00187	CcSEcCtD
Acenocoumarol—Nausea—Midazolam—epilepsy syndrome	0.00013	0.00187	CcSEcCtD
Acenocoumarol—Diarrhoea—Zonisamide—epilepsy syndrome	0.00013	0.00186	CcSEcCtD
Acenocoumarol—Vomiting—Vigabatrin—epilepsy syndrome	0.000129	0.00185	CcSEcCtD
Acenocoumarol—Nausea—Levetiracetam—epilepsy syndrome	0.000128	0.00184	CcSEcCtD
Acenocoumarol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000128	0.00184	CcSEcCtD
Acenocoumarol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000128	0.00183	CcSEcCtD
Acenocoumarol—Vomiting—Diazepam—epilepsy syndrome	0.000127	0.00183	CcSEcCtD
Acenocoumarol—Dermatitis—Diazepam—epilepsy syndrome	0.000126	0.00181	CcSEcCtD
Acenocoumarol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000125	0.00179	CcSEcCtD
Acenocoumarol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000124	0.00178	CcSEcCtD
Acenocoumarol—Nausea—Fosphenytoin—epilepsy syndrome	0.000124	0.00178	CcSEcCtD
Acenocoumarol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000123	0.00177	CcSEcCtD
Acenocoumarol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000123	0.00177	CcSEcCtD
Acenocoumarol—Vomiting—Felbamate—epilepsy syndrome	0.000123	0.00177	CcSEcCtD
Acenocoumarol—Dermatitis—Felbamate—epilepsy syndrome	0.000122	0.00175	CcSEcCtD
Acenocoumarol—Nausea—Vigabatrin—epilepsy syndrome	0.000121	0.00173	CcSEcCtD
Acenocoumarol—Vomiting—Zonisamide—epilepsy syndrome	0.000121	0.00173	CcSEcCtD
Acenocoumarol—Dermatitis—Zonisamide—epilepsy syndrome	0.000119	0.00171	CcSEcCtD
Acenocoumarol—Nausea—Diazepam—epilepsy syndrome	0.000119	0.00171	CcSEcCtD
Acenocoumarol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000118	0.0017	CcSEcCtD
Acenocoumarol—Vomiting—Clonazepam—epilepsy syndrome	0.000116	0.00167	CcSEcCtD
Acenocoumarol—Warfarin—CYP2C19—epilepsy syndrome	0.000116	0.0512	CrCbGaD
Acenocoumarol—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000116	0.00166	CcSEcCtD
Acenocoumarol—Alopecia—Topiramate—epilepsy syndrome	0.000115	0.00166	CcSEcCtD
Acenocoumarol—Vomiting—Phenytoin—epilepsy syndrome	0.000115	0.00166	CcSEcCtD
Acenocoumarol—Dermatitis—Clonazepam—epilepsy syndrome	0.000115	0.00165	CcSEcCtD
Acenocoumarol—Nausea—Felbamate—epilepsy syndrome	0.000115	0.00165	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000115	0.00165	CcSEcCtD
Acenocoumarol—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000115	0.00165	CcSEcCtD
Acenocoumarol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000115	0.00164	CcSEcCtD
Acenocoumarol—Dermatitis—Phenytoin—epilepsy syndrome	0.000114	0.00164	CcSEcCtD
Acenocoumarol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000114	0.00163	CcSEcCtD
Acenocoumarol—Nausea—Zonisamide—epilepsy syndrome	0.000113	0.00162	CcSEcCtD
Acenocoumarol—Vomiting—Carbamazepine—epilepsy syndrome	0.00011	0.00158	CcSEcCtD
Acenocoumarol—Dermatitis—Carbamazepine—epilepsy syndrome	0.000109	0.00157	CcSEcCtD
Acenocoumarol—Nausea—Clonazepam—epilepsy syndrome	0.000108	0.00156	CcSEcCtD
Acenocoumarol—Nausea—Phenytoin—epilepsy syndrome	0.000108	0.00155	CcSEcCtD
Acenocoumarol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000107	0.00154	CcSEcCtD
Acenocoumarol—Vomiting—Lamotrigine—epilepsy syndrome	0.000106	0.00153	CcSEcCtD
Acenocoumarol—Urticaria—Valproic Acid—epilepsy syndrome	0.000106	0.00152	CcSEcCtD
Acenocoumarol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000105	0.00151	CcSEcCtD
Acenocoumarol—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000105	0.00151	CcSEcCtD
Acenocoumarol—Decreased appetite—Pregabalin—epilepsy syndrome	0.000105	0.0015	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000104	0.00149	CcSEcCtD
Acenocoumarol—Nausea—Carbamazepine—epilepsy syndrome	0.000103	0.00148	CcSEcCtD
Acenocoumarol—Nausea—Lamotrigine—epilepsy syndrome	9.94e-05	0.00143	CcSEcCtD
Acenocoumarol—Hypersensitivity—Valproic Acid—epilepsy syndrome	9.8e-05	0.00141	CcSEcCtD
Acenocoumarol—Decreased appetite—Gabapentin—epilepsy syndrome	9.58e-05	0.00138	CcSEcCtD
Acenocoumarol—Urticaria—Pregabalin—epilepsy syndrome	9.55e-05	0.00137	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.52e-05	0.00137	CcSEcCtD
Acenocoumarol—Body temperature increased—Pregabalin—epilepsy syndrome	9.51e-05	0.00136	CcSEcCtD
Acenocoumarol—Diarrhoea—Valproic Acid—epilepsy syndrome	9.1e-05	0.00131	CcSEcCtD
Acenocoumarol—Hypersensitivity—Pregabalin—epilepsy syndrome	8.86e-05	0.00127	CcSEcCtD
Acenocoumarol—Urticaria—Gabapentin—epilepsy syndrome	8.76e-05	0.00126	CcSEcCtD
Acenocoumarol—Body temperature increased—Gabapentin—epilepsy syndrome	8.72e-05	0.00125	CcSEcCtD
Acenocoumarol—Vomiting—Valproic Acid—epilepsy syndrome	8.46e-05	0.00121	CcSEcCtD
Acenocoumarol—Flunitrazepam—CYP2C19—epilepsy syndrome	8.44e-05	0.0374	CrCbGaD
Acenocoumarol—Dermatitis—Valproic Acid—epilepsy syndrome	8.38e-05	0.0012	CcSEcCtD
Acenocoumarol—Diarrhoea—Pregabalin—epilepsy syndrome	8.23e-05	0.00118	CcSEcCtD
Acenocoumarol—Hypersensitivity—Gabapentin—epilepsy syndrome	8.12e-05	0.00117	CcSEcCtD
Acenocoumarol—Decreased appetite—Topiramate—epilepsy syndrome	8.06e-05	0.00116	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.01e-05	0.00115	CcSEcCtD
Acenocoumarol—Nausea—Valproic Acid—epilepsy syndrome	7.9e-05	0.00113	CcSEcCtD
Acenocoumarol—Vomiting—Pregabalin—epilepsy syndrome	7.65e-05	0.0011	CcSEcCtD
Acenocoumarol—Dermatitis—Pregabalin—epilepsy syndrome	7.57e-05	0.00109	CcSEcCtD
Acenocoumarol—Diarrhoea—Gabapentin—epilepsy syndrome	7.54e-05	0.00108	CcSEcCtD
Acenocoumarol—Urticaria—Topiramate—epilepsy syndrome	7.37e-05	0.00106	CcSEcCtD
Acenocoumarol—Body temperature increased—Topiramate—epilepsy syndrome	7.33e-05	0.00105	CcSEcCtD
Acenocoumarol—Phenprocoumon—ALB—epilepsy syndrome	7.23e-05	0.032	CrCbGaD
Acenocoumarol—Nausea—Pregabalin—epilepsy syndrome	7.14e-05	0.00103	CcSEcCtD
Acenocoumarol—Vomiting—Gabapentin—epilepsy syndrome	7.01e-05	0.00101	CcSEcCtD
Acenocoumarol—Dermatitis—Gabapentin—epilepsy syndrome	6.95e-05	0.000997	CcSEcCtD
Acenocoumarol—Hypersensitivity—Topiramate—epilepsy syndrome	6.83e-05	0.000981	CcSEcCtD
Acenocoumarol—Nausea—Gabapentin—epilepsy syndrome	6.55e-05	0.00094	CcSEcCtD
Acenocoumarol—Warfarin—ALB—epilepsy syndrome	6.41e-05	0.0284	CrCbGaD
Acenocoumarol—Diarrhoea—Topiramate—epilepsy syndrome	6.35e-05	0.000911	CcSEcCtD
Acenocoumarol—Vomiting—Topiramate—epilepsy syndrome	5.9e-05	0.000847	CcSEcCtD
Acenocoumarol—Dermatitis—Topiramate—epilepsy syndrome	5.84e-05	0.000839	CcSEcCtD
Acenocoumarol—Nausea—Topiramate—epilepsy syndrome	5.51e-05	0.000791	CcSEcCtD
Acenocoumarol—Nitrazepam—ABCB1—epilepsy syndrome	4.03e-05	0.0179	CrCbGaD
Acenocoumarol—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	6.75e-06	0.000366	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GBE1—epilepsy syndrome	6.75e-06	0.000366	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NT5E—epilepsy syndrome	6.7e-06	0.000363	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ALAD—epilepsy syndrome	6.7e-06	0.000363	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.66e-06	0.000361	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NEU1—epilepsy syndrome	6.62e-06	0.000359	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—UPB1—epilepsy syndrome	6.62e-06	0.000359	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ATIC—epilepsy syndrome	6.62e-06	0.000359	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.59e-06	0.000358	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—COX3—epilepsy syndrome	6.52e-06	0.000354	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—CDC42—epilepsy syndrome	6.48e-06	0.000351	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CACNA1A—epilepsy syndrome	6.39e-06	0.000346	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ALDH7A1—epilepsy syndrome	6.39e-06	0.000346	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	6.37e-06	0.000345	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	6.34e-06	0.000344	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ADK—epilepsy syndrome	6.3e-06	0.000341	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	6.3e-06	0.000341	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—FAR1—epilepsy syndrome	6.3e-06	0.000341	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	6.3e-06	0.000341	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PDXK—epilepsy syndrome	6.3e-06	0.000341	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CERS1—epilepsy syndrome	6.3e-06	0.000341	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ST3GAL3—epilepsy syndrome	6.25e-06	0.000339	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	6.18e-06	0.000335	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	6.18e-06	0.000335	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	6.18e-06	0.000335	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PFKL—epilepsy syndrome	6.18e-06	0.000335	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	6.18e-06	0.000335	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	6.17e-06	0.000335	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	6.15e-06	0.000334	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GBE1—epilepsy syndrome	6.15e-06	0.000334	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ADSL—epilepsy syndrome	6.13e-06	0.000332	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.04e-06	0.000328	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NT5E—epilepsy syndrome	6.01e-06	0.000326	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALAD—epilepsy syndrome	6.01e-06	0.000326	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.01e-06	0.000326	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GLUL—epilepsy syndrome	6.01e-06	0.000326	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6e-06	0.000326	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CACNA1D—epilepsy syndrome	5.9e-06	0.00032	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	5.78e-06	0.000314	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—FYN—epilepsy syndrome	5.77e-06	0.000313	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GAMT—epilepsy syndrome	5.76e-06	0.000312	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	5.76e-06	0.000312	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PNPO—epilepsy syndrome	5.76e-06	0.000312	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	5.76e-06	0.000312	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	5.74e-06	0.000311	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	5.74e-06	0.000311	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NEU1—epilepsy syndrome	5.65e-06	0.000307	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ATIC—epilepsy syndrome	5.65e-06	0.000307	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—UPB1—epilepsy syndrome	5.65e-06	0.000307	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	5.63e-06	0.000305	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	5.61e-06	0.000304	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—YWHAZ—epilepsy syndrome	5.55e-06	0.000301	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—TXNRD1—epilepsy syndrome	5.52e-06	0.000299	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ADSL—epilepsy syndrome	5.5e-06	0.000298	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NT5E—epilepsy syndrome	5.48e-06	0.000297	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALAD—epilepsy syndrome	5.48e-06	0.000297	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.48e-06	0.000297	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	5.44e-06	0.000295	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.43e-06	0.000295	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GLUL—epilepsy syndrome	5.39e-06	0.000292	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—AQP1—epilepsy syndrome	5.35e-06	0.00029	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.35e-06	0.00029	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.35e-06	0.00029	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.34e-06	0.000289	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	5.29e-06	0.000287	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.26e-06	0.000285	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GBE1—epilepsy syndrome	5.26e-06	0.000285	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	5.26e-06	0.000285	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	5.23e-06	0.000284	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	5.23e-06	0.000284	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	5.22e-06	0.000283	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.14e-06	0.000279	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.14e-06	0.000279	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	5.12e-06	0.000278	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	5.08e-06	0.000276	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.03e-06	0.000273	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ADSL—epilepsy syndrome	5.01e-06	0.000272	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	4.95e-06	0.000268	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	4.94e-06	0.000268	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PLAU—epilepsy syndrome	4.92e-06	0.000267	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.92e-06	0.000267	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CHRM3—epilepsy syndrome	4.84e-06	0.000263	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—KCNJ11—epilepsy syndrome	4.84e-06	0.000263	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.83e-06	0.000262	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	4.81e-06	0.000261	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—AQP1—epilepsy syndrome	4.81e-06	0.000261	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.77e-06	0.000259	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.77e-06	0.000259	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.77e-06	0.000259	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.77e-06	0.000259	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.77e-06	0.000259	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NT5E—epilepsy syndrome	4.69e-06	0.000254	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALAD—epilepsy syndrome	4.69e-06	0.000254	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.62e-06	0.00025	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PRKCB—epilepsy syndrome	4.58e-06	0.000248	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—NOS2—epilepsy syndrome	4.52e-06	0.000245	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.51e-06	0.000245	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.51e-06	0.000245	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	4.47e-06	0.000242	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	4.47e-06	0.000242	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.42e-06	0.00024	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.38e-06	0.000238	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	4.37e-06	0.000237	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.36e-06	0.000237	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.36e-06	0.000237	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.36e-06	0.000237	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.35e-06	0.000236	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.35e-06	0.000236	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ADSL—epilepsy syndrome	4.29e-06	0.000232	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.21e-06	0.000228	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GLUL—epilepsy syndrome	4.2e-06	0.000228	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.2e-06	0.000228	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	4.12e-06	0.000224	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.06e-06	0.00022	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.06e-06	0.00022	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.05e-06	0.00022	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.97e-06	0.000215	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.96e-06	0.000215	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.96e-06	0.000215	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCG2—epilepsy syndrome	3.95e-06	0.000214	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.86e-06	0.000209	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP2C19—epilepsy syndrome	3.85e-06	0.000209	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP11A1—epilepsy syndrome	3.82e-06	0.000207	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.81e-06	0.000207	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.8e-06	0.000206	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.75e-06	0.000203	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.71e-06	0.000201	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.69e-06	0.0002	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.62e-06	0.000196	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.62e-06	0.000196	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.62e-06	0.000196	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.6e-06	0.000195	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.54e-06	0.000192	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP2D6—epilepsy syndrome	3.45e-06	0.000187	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.45e-06	0.000187	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.45e-06	0.000187	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.43e-06	0.000186	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.41e-06	0.000185	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.39e-06	0.000184	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.39e-06	0.000184	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.38e-06	0.000183	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.31e-06	0.000179	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ADRA2A—epilepsy syndrome	3.28e-06	0.000178	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—BCHE—epilepsy syndrome	3.27e-06	0.000177	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.24e-06	0.000176	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	3.24e-06	0.000176	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.23e-06	0.000175	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.18e-06	0.000173	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.15e-06	0.000171	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.15e-06	0.000171	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.13e-06	0.00017	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—SLC2A1—epilepsy syndrome	3.12e-06	0.000169	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.11e-06	0.000168	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.11e-06	0.000168	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.1e-06	0.000168	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.09e-06	0.000168	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PLCB1—epilepsy syndrome	3.09e-06	0.000167	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—TH—epilepsy syndrome	3.08e-06	0.000167	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.03e-06	0.000164	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.98e-06	0.000161	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.95e-06	0.00016	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.94e-06	0.000159	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.89e-06	0.000157	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.83e-06	0.000154	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.82e-06	0.000153	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.8e-06	0.000152	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.77e-06	0.00015	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.76e-06	0.00015	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—TH—epilepsy syndrome	2.76e-06	0.00015	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.72e-06	0.000147	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.69e-06	0.000146	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—SRC—epilepsy syndrome	2.69e-06	0.000146	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.69e-06	0.000146	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.68e-06	0.000145	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.67e-06	0.000145	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.66e-06	0.000144	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.62e-06	0.000142	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.61e-06	0.000142	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.61e-06	0.000142	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—HMOX1—epilepsy syndrome	2.57e-06	0.000139	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.55e-06	0.000139	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CAT—epilepsy syndrome	2.53e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.53e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—TH—epilepsy syndrome	2.52e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.48e-06	0.000134	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCB1—epilepsy syndrome	2.46e-06	0.000134	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.42e-06	0.000131	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.41e-06	0.000131	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.3e-06	0.000125	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.3e-06	0.000125	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GPX1—epilepsy syndrome	2.29e-06	0.000124	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.29e-06	0.000124	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.27e-06	0.000123	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.21e-06	0.00012	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.18e-06	0.000118	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.16e-06	0.000117	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—TH—epilepsy syndrome	2.15e-06	0.000117	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.13e-06	0.000116	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.12e-06	0.000115	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.1e-06	0.000114	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.08e-06	0.000113	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.07e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.06e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.06e-06	0.000111	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.02e-06	0.000109	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—AGT—epilepsy syndrome	2.01e-06	0.000109	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—APOE—epilepsy syndrome	1.97e-06	0.000107	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.87e-06	0.000102	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.86e-06	0.000101	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.8e-06	9.78e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.8e-06	9.74e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.77e-06	9.62e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.77e-06	9.61e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.77e-06	9.58e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.77e-06	9.58e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.72e-06	9.34e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—POMC—epilepsy syndrome	1.69e-06	9.17e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.68e-06	9.13e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—AKT1—epilepsy syndrome	1.67e-06	9.06e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.67e-06	9.03e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TH—epilepsy syndrome	1.66e-06	9e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.64e-06	8.91e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.61e-06	8.73e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.6e-06	8.69e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.52e-06	8.23e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.4e-06	7.62e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.39e-06	7.51e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.38e-06	7.5e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.38e-06	7.5e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.38e-06	7.46e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.37e-06	7.41e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTGS2—epilepsy syndrome	1.35e-06	7.31e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.33e-06	7.21e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.26e-06	6.84e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.24e-06	6.7e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.21e-06	6.56e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.18e-06	6.41e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.1e-06	5.98e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.08e-06	5.88e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.08e-06	5.85e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.06e-06	5.76e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	9.43e-07	5.11e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—POMC—epilepsy syndrome	9.13e-07	4.95e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALB—epilepsy syndrome	8.32e-07	4.51e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	7.28e-07	3.95e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—AKT1—epilepsy syndrome	6.78e-07	3.67e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—AKT1—epilepsy syndrome	6.08e-07	3.3e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AKT1—epilepsy syndrome	5.55e-07	3.01e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AKT1—epilepsy syndrome	4.74e-07	2.57e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.66e-07	1.98e-05	CbGpPWpGaD
